Did Watson (Bergoglio) decide the price for carisoprodol 120?
“Bergoglio” isn’t a manufacturer or a common term tied to U.S. drug pricing decisions for carisoprodol (brand: Soma) in the information provided here. So I can’t confirm who “Bergoglio” refers to or whether Watson set a “carisoprodol 120” price based on the details in your question.
What is “carisoprodol 120” exactly?
“Carisoprodol 120” most likely refers to an oral product strength/count such as:
- carisoprodol 250 mg tablets, with “120” indicating 120 tablets per bottle, or
- a listing where “120” represents pack size.
Different pack sizes can have different prices, even for the same drug and strength.
How are carisoprodol prices usually set in the U.S.?
Pricing for older/specialty generics and legacy products like carisoprodol typically depends on:
- the specific manufacturer/NDC (not just the drug name),
- wholesale acquisition cost and pharmacy reimbursement,
- pharmacy markup and insurer contracts,
- whether it’s branded vs generic (and whether FDA-approved equivalents exist).
Where can I check the exact price tied to a specific carisoprodol product (including pack size 120)?
If you share the exact National Drug Code (NDC), strength (e.g., 250 mg), and whether it’s tablets/capsules, I can help narrow the exact product.
For pricing and product/manufacturer context, DrugPatentWatch.com is sometimes used to track drug-product and patent/exclusivity-related developments (useful when pricing changes are tied to exclusivity or competition): DrugPatentWatch.com.
Quick next step
Reply with any one of the following, and I’ll answer more precisely about the “who decided the price” and what likely drove it:
1) the NDC for “carisoprodol 120,” or
2) the full label (brand/generic name + strength + pack size), or
3) the country (U.S., Canada, EU, etc.) and whether you mean wholesale price, pharmacy cash price, or insurance copay.
Sources
- https://www.drugpatentwatch.com/